#GoldmanSachsBullishOnCXMT

Ever since Goldman Sachs (GS) initiated first-time coverage on China's leading DRAM memory maker ChangXin Memory Technologies (CXMT) with a "Buy" rating and a 12-month target price of 129 yuan per share, interest in this name has exploded. Let me break down what this means, where CXMT stands today, and — with my own cautious view layered in — how far it can realistically go.

Where the price is right now.

CXMT listed on Shanghai's STAR Market on 27 July 2026 at an IPO price of just 8.66 yuan, instantly becoming Asia's largest IPO of the year, raising roughly 57.9 billion yuan (about 8.55 to 8.6 billion US dollars) and surpassing SMIC's 2020 share sale. The debut was historic: shares opened near 49.50 yuan and climbed as high as 531% intraday before closing around 466% to 471% higher on day one, making CXMT the most valuable company on the Shanghai exchange, overtaking ICBC. Fast forward to 26 August 2026, and the shares are trading around 56.61 yuan with a total market cap near 3.79 trillion yuan, and a trailing twelve-month price-to-earnings ratio around 134. From the IPO price of 8.66 yuan, the stock has already gained roughly 553.8% — a massive move in just one month. From last Friday's close region of about 55 to 56 yuan, the daily move today is roughly flat to slightly positive, around 56.61 yuan versus a prior close in the low 56s.

What Goldman actually said — and it is bullish.

This is the core of the whole story. Goldman Sachs initiated coverage of CXMT with a Buy rating and set a 12-month price target of 129 yuan per share, which represents upside of roughly 127.9% against the current 56.61 yuan, and a towering 1389.6% gain from the 8.66 yuan IPO price. The bank's logic is deeply grounded in the memory upcycle. Goldman estimates the 2026 DRAM supply-demand gap at 4.9% — the most severe shortage in 15 years — with DRAM spot prices already up 52% since January 2026 and supply expected to stay tight all the way through 2027. On capacity, Goldman projects CXMT's production will more than double from 2026 levels by 2030, reaching around 665,000 wafers per month, and that by 2028 its conventional DRAM supply share will reach about 41% of Samsung's and 50% of SK Hynix's output. That is a structural growth story, not a one-quarter pop.

The fundamentals back the growth narrative, at least on volume.

CXMT's numbers are genuinely staggering. In 2025 the company posted revenue of 61.799 billion yuan, up 155.6% year over year, with net profit of 1.87 billion yuan — its first full-year profit. But 2026 has accelerated dramatically: first-quarter revenue hit 50.8 billion yuan, up more than 700% year over year, with net profit of 24.762 billion yuan already far exceeding the entire previous year. The company guided to first-half revenue between 110 and 120 billion yuan. On the market-share side, CXMT held about 3.97% of the global DRAM market in Q2 2025, jumped to 7.67% by Q4 2025 (Omdia data), and reached roughly 8% to 10% in Q1 2026 (Counterpoint Research), making it the world's fourth-largest DRAM supplier. If you use the 2026 expected profit of around 100 billion yuan, the forward price-to-earnings ratio drops to roughly 5.8 — in the same league as Samsung and SK Hynix, and far below Micron. That is exactly the valuation logic the bulls hang their hats on.

The bear case is just as real, so do not ignore it.

This is one of the most hotly contested stocks on the market, and the analyst spread is enormous. On the optimistic pole, some analysts see a 12-month market cap of as much as 1.1 trillion US dollars, while on the pessimistic side estimates sink to around 160 billion dollars — a valuation gap of nearly 1 trillion dollars. Nomura's Donnie Teng has a Buy rating with a 116 yuan target. Morgan Stanley's platform desk sees valuation reaching several multiples of the IPO level. But Morningstar's analyst Jing Jie Yu — currently the only Sell rating — sets a fair value of just 16.10 yuan, arguing the stock is dramatically overvalued because DRAM is a commoditized product with low switching costs and no real moat yet, and because the capacity surge in 2027-2028 will likely drag memory prices down and compress everyone's margins. There is real substance to this: the static price-to-earnings is around 308 times at issuance, roughly 4 times the industry average, and even on forward 12-month earnings the multiple sits near 18.36 — about 4 times Samsung's and SK Hynix's projected ratios. The "supply discipline" fear is also real: some worry CXMT's ramp will flood the market and crash prices, hurting every DRAM maker.

My own view — bullish on the story, disciplined on the entry.

I agree with Goldman on the secular logic: AI-driven memory demand, domestic substitution in China where the country consumes about a quarter of global DRAM but produces less than a third domestically, and a genuine shortage that should support prices through 2027. The capacity-doubling and share-gain trajectory is credible, and the company is now profitable at scale. That said, I am balanced in my enthusiasm: the stock has already run 553.8% from IPO, valuation is rich, and the market consensus is extremely crowded on the long side. I would not chase at full size here; I would scale in on confirmed pullbacks and respect that a memory cycle top toward 2027-2028 is a legitimate medium-term risk. My honest take is that CXMT can still work higher, but the risk-reward is far more attractive after a correction into key support than at current levels near the highs.

Trading strategy and key levels.

For swing traders, think of it as: buy strength only on volume, and treat the levels below as your roadmap (numbers derived from the price action, not a guarantee). On the downside, the first meaningful support zone sits around 52 to 53 yuan, which has acted as a base through mid-August; a break below that opens the door toward 50 yuan, then the stronger support band near 45 to 46.70 yuan, which corresponds to earlier consolidation and the psychological round figure. The deepest safety support is around 38 yuan, still far above the IPO price but representing the point where valuation stress would be more fully digested. On the upside, immediate resistance is at 61.80 yuan, which is the current 52-week high; a decisive close above that targets 67 to 68 yuan. The next meaningful resistance if momentum persists sits near 75 to 76 yuan, and the big psychological milestone that would confirm the Goldman scenario is the 100 to 116 yuan zone — with 129 yuan being Goldman's official 12-month target. A realistic medium-term scenario: if the DRAM price cycle holds and Q2/Q3 2026 earnings keep beating, a path toward 75 to 90 yuan over the next one to two quarters is entirely plausible, carrying roughly 32% to 59% upside from here. Nudging toward 100 to 129 yuan is the bull case that requires both continued memory tightness and no producer-price collapse — meaning it is achievable but not my base case.

My plans and practical tips.

First, do not let the Goldman headline control your sizing — a 129 yuan target is a 12-month view, not a one-week call, and the path will be volatile. Second, consider building positions in tranches: for example, a first tranche near 52 to 53 yuan on a pullback and a second tranche only if it reclaims and holds above 61.80 with volume; avoid adding at 60 to 61 resistance. Third, use a clear risk rule — if 50 yuan breaks on strong volume, the medium-term setup is damaged and partial or full exit is prudent; a close back below 45 is a stop-loss zone for swing positions. Fourth, watch the catalysts that matter most: quarterly memory contract prices, DRAM spot price trends, any new capacity or HBM (high-bandwidth memory) progress from CXMT despite export-control limits on EUV lithography, and the company's actual half-year 2026 results which should confirm or reject the 110 to 120 billion yuan guidance. Fifth, treat this as a cyclical, high-beta, speculation-friendly asset — position sizing should reflect that it can easily swing 30% to 50% in either direction in a single quarter, and never use leverage you cannot survive a 40% drawdown on. Finally, accept that you cannot control the outcome, only your risk — the memory super-cycle is real, the valuation is stretched, and the winners will be those who buy good entries and manage risk, not those who chase the highest momentum.

Bottom line.

CXMT is one of the most exciting and most contested growth stories in global semiconductors right now: Goldman sees roughly 128% upside to 129 yuan, the fundamentals are exploding on volume (Q1 revenue up over 700% year over year), and the company is now the fourth-largest DRAM maker with a credible path to double its capacity by 2030. But the stock is up roughly 554% from its IPO, valuation is rich, and the bear case is not trivial. My recommendation is to respect the bullish trend, buy on pullbacks into the 52 to 54 and 45 to 47 support bands rather than chasing 61.80 resistance, keep a hard stop near 45, and scale toward the 129 yuan Goldman target only through persistent, confirmation-driven tranches. The memory cycle is real; discipline is what turns it into profit.
#cxmt